Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19.


Journal

Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 17 11 2020
revised: 11 02 2021
accepted: 24 03 2021
pubmed: 13 4 2021
medline: 13 4 2021
entrez: 12 4 2021
Statut: ppublish

Résumé

The fate of protective immunity following mild severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection remains ill defined. Here, we characterize antibody responses in a cohort of participants recovered from mild SARS-CoV-2 infection with follow-up to 6 months. We measure immunoglobulin A (IgA), IgM, and IgG binding and avidity to viral antigens and assess neutralizing antibody responses over time. Furthermore, we correlate the effect of fever, gender, age, and time since symptom onset with antibody responses. We observe that total anti-S trimer, anti-receptor-binding domain (RBD), and anti-nucleocapsid protein (NP) IgG are relatively stable over 6 months of follow-up, that anti-S and anti-RBD avidity increases over time, and that fever is associated with higher levels of antibodies. However, neutralizing antibody responses rapidly decay and are strongly associated with declines in IgM levels. Thus, while total antibody against SARS-CoV-2 may persist, functional antibody, particularly IgM, is rapidly lost. These observations have implications for the duration of protective immunity following mild SARS-CoV-2 infection.

Identifiants

pubmed: 33842901
doi: 10.1016/j.xcrm.2021.100253
pii: S2666-3791(21)00069-0
pmc: PMC8020863
doi:

Substances chimiques

Antibodies, Neutralizing 0
Immunoglobulin G 0
Immunoglobulin M 0
Nucleocapsid Proteins 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Pagination

100253

Subventions

Organisme : NIAID NIH HHS
ID : K08 AI135072
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140951
Pays : United States

Informations de copyright

© 2021 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Auteurs

Whitney E Harrington (WE)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.

Olesya Trakhimets (O)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Daniela V Andrade (DV)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Nicholas Dambrauskas (N)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Andrew Raappana (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Yonghou Jiang (Y)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

John Houck (J)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

William Selman (W)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Ashton Yang (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Vladimir Vigdorovich (V)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Winnie Yeung (W)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Micaela Haglund (M)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Jackson Wallner (J)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Alyssa Oldroyd (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Samantha Hardy (S)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Samuel W A Stewart (SWA)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Ana Gervassi (A)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.

Wes Van Voorhis (W)

Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109, USA.

Lisa Frenkel (L)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.

D Noah Sather (DN)

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH